OR7C1

Across TCGA pan-cancer cohorts, OR7C1 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated OR7C1 data layer compared with 23 for mass-spec protein and 3 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher OR7C1 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated OR7C1 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

HNSC, GBM, and UCEC are the cancer types where OR7C1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Median	II,III,IV	0.734	0.959	.014	14	view →
GBM	OS	Median	All	0.355	0.627	.020	3	view →
UCEC	OS	Median	All	1.000	0.839	.048	2	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

OR7C1–HNSC (OS)

Open the HNSC breakdown →